|
569 Keep
pharmacists close to pharmacies Pharmacists should not be absent from pharmacies for any great length of time, professional representatives say in a series of cautious responses to the Department of Health's “Vision for pharmacy”
...more
569 Implications
for Society in better regulation report Independent regulators
should all have appeals mechanisms that allow affected parties to appeal
against decisions before having to resort to judicial review, the Government's
Better Regulation Task Force has said ...more
570 New
computerised medicines system is installed at Charing Cross Hospital The
Charing Cross Hospital site of the Hammersmith Hospitals NHS Trust is
the first European hospital to pilot ServeRx, a computerised system for
the management of medicines from the point of prescribing to administration
...more
570 Petition
planned for Charter referendum The Save Our Society group
is organising a petition aimed at compelling the Royal Pharmaceutical
Society to hold a referendum of the membership on its draft Charter ...more
570 Pharmacists
told to target PCTs in preparation for year of changes Pharmacists
need to be prepared for significant changes over the coming months, according
to AAH Pharmaceuticals ...more
571 Scotland
funds 100 more prescriber training places New funding to train
100 community pharmacists in Scotland to become supplementary prescribers
was announced on 21 October. All 100 places will be on the course run
at the Robert Gordon University, Aberdeen, starting before March 2004
...more
571 Pharmacy
role in NHS Direct grows NHS Direct is expanding the number
of pharmacists supporting its staff with several sites reaching agreements
with local medicines information services for additional advice and training
...more
571 Roll-out
for minor ailments scheme The direct supply of medicines scheme
has been rolled out to include 176 community pharmacies in Scotland ...more
571 Scottish heart failure project gains £300,000 award of lottery funding A pharmacist-led project in Glasgow has been granted £300,000 of lottery funds over three years to tackle heart failure
...more
571 Lamisil
reclassifications sought Novartis Consumer Health has applied
to have Lamisil AT 1 per cent spray and Lamisil AT cream (terbinafine
hydrochloride) reclassified as general sale list medicines ...more |
572 Bulletin
criticises MHRA and industry for “epidemic of misleading adverts” The
Medicines and Healthcare products Regulatory Agency (MHRA) is failing
to control the marketing activities of the pharmaceutical industry, according
to the Drug and Therapeutics Bulletin ...more
572 Agency stops
discount schemes Three pharmaceutical wholesalers have halted
or modified promotional schemes which the Medicines and Healthcare products
Regulatory Agency claims broke the law on gifts to health professionals
...more
572 DTB reviews
magnesium and isotretinoin The unlicensed use of intravenous
magnesium sulphate in acute severe asthma is not supported by current
evidence, according to the Drug and Therapeutics Bulletin ...more
572 Ramadan starts
on 27 October Pharmacists should be aware that the Muslim
fasting period of Ramadan begins on 27 October ...more
572 Variation
in diabetes response Patients with a particular genetic subtype
of diabetes have increased sensitivity to sulphonylureas, researchers
say ...more
572 Weight loss
with antiepileptic Four cases of considerable weight loss
associated with taking levetiracetam (Keppra) are reported in the BMJ ...more
572 Avoid anaemia
treatment in cancer Treating anaemia with erythropoietin (epoetin
beta) in patients with head and neck cancer might make their outcome
worse, researchers say ...more
573 Reassuring
results seen for epilepsy in pregnancy Preliminary results
from the United Kingdom epilepsy and pregnancy register are encouraging,
indicating that 95 per cent of babies born to women with epilepsy show
no major congenital malformations ...more
573 Current drugs
fail to halt late-onset malaria Most cases of late-onset malaria
are not prevented by commonly used antimalarials, according to researchers
...more
573 Depo-Provera
effect on bones varies throughout skeleton Long-term use of
depot medroxyprogesterone acetate (DMPA, Depo-Provera) appears to be
associated with decreased bone density at the lumbar spine and hip, but
not at the forearm, according to initial results of an ongoing trial
...more
574 When patients
asked about medicines Pharmacists and other health care professionals
were involved in a variety of activities last week (12–18 October)
marking Ask About Medicines Week ...more |
